Art

J-GLOBAL ID：202002254359514015   Reference number：20A1855484

Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naieve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials

HER2陰性胃癌(S-1アジュバント療法に再発または化学療法未処置で進行)に対する5週ごとのS-1-シスプラチンと3週ごとのカペシタビン-シスプラチンの比較:HERBIS-2(OGSG1103)およびHERBIS-4A(OGSG1105)試験のプール解析

Author (17)： Kawakami Hisato (Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka-sayama, Osaka, Japan) ,  Fujitani Kazumasa (Department of Surgery, Osaka Prefectural General Medical Center, Osaka-shi, Japan) ,  Matsuyama Jin (Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan) ,  Akamaru Yusuke (Department of Surgery, Ikeda Municipal Hospital, Ikeda, Japan) ,  Tamura Shigeyuki (Department of Surgery, Yao Municipal Hospital, Yao, Japan) ,  Endo Shunji (Department of Surgery, Faculty of Medicine, Kindai University, Osaka-sayama, Japan) ,  Kimura Yutaka (Department of Surgery, Sakai City Medical Center, Sakai, Japan) ,  Makari Youichi (Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan) ,  Tamura Takao (Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan) ,  Sugimoto Naotoshi (Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan) ,  Sakai Daisuke (Cancer Center, Izumi City General Hospital, Izumi, Japan) ,  Tsujinaka Toshimasa (Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan) ,  Goto Masahiro (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan) ,  Kurokawa Yukinori (Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan) ,  Shimokawa Toshio (Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan) ,  Satoh Taroh (Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan) ,  for the Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
Material： International Journal of Clinical Oncology (Web)
Volume： 25  Issue： 9  Page： 1635-1643  Publication year： 2020 
JST Material Number： U1599A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1855484&from=J-GLOBAL&jstjournalNo=U1599A") }}

Author keywords (5)： Advanced gastric cancer ,  Recurrent gastric cancer ,  S-1 ,  Capecitabine ,  Cisplatin

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (2)： TS-1 ,  Capecitabine

Terms in the title (11)： HER2 ,  胃癌 ,  S-1 ,  アジュバント療法 ,  再発 ,  化学療法 ,  処置 ,  シスプラチン ,  カペシタビン ,  試験 ,  解析